Cocoon Biotech, based in Mansfield, Massachusetts, utilizes the unique properties of fibroin, a protein derived from the cocoon of the silkworm, to provide long-lasting pain relief and potentially slow down disease progression in joints. Their mission is to significantly improve the treatment of osteoarthritis, addressing both symptoms and disease progression. By leveraging the strength, lubrication, and biocompatibility of the silk protein, Cocoon Biotech aims to fill the treatment gap in osteoarthritis and bring a healthier and more productive life to patients worldwide.